Ailurus Biotechnology Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Ailurus Biotechnology General Information

Description

Developer of biocomputing technology designed for medical health. The company's products mainly focus on an IT-based synthetic biology platform that enables biological product development to be as low-cost and fast-iterating as IT. It uses synthetic biology, where cells are deeply transformed into a "micro-laboratory" to cultivate hundreds of millions of cells at the same time, enabling to carrying out of hundreds of millions of experiments in parallel on a large scale.

Contact Information

Website
www.ailurus.bio
Formerly Known As
Shenzhen Xunzhu Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room A1617, Building 9, Zone 2, Shenzhen Bay Science and Technology Ecological Park
  • Number 3609 Baishi Road, Gaoxinqu Community, Yuehai Street, Nanshan District
  • Shenzhen, Guangdong 518000
  • China
+86 186
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • Room A1617, Building 9, Zone 2, Shenzhen Bay Science and Technology Ecological Park
  • Number 3609 Baishi Road, Gaoxinqu Community, Yuehai Street, Nanshan District
  • Shenzhen, Guangdong 518000
  • China
+86 186

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ailurus Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Startup
3. Seed Round 18-Aug-2021 Completed Startup
2. Accelerator/Incubator 12-Oct-2020 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Ailurus Biotechnology’s complete valuation and funding history, request access »

Ailurus Biotechnology Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
5Y Capital Venture Capital Minority
Shanghai Youwei Zhilin Investment Management Venture Capital Minority
Miracleplus Accelerator/Incubator Minority
Hello Tomorrow Accelerator/Incubator Minority
iGem Startups Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Ailurus Biotechnology FAQs

  • When was Ailurus Biotechnology founded?

    Ailurus Biotechnology was founded in 2020.

  • Where is Ailurus Biotechnology headquartered?

    Ailurus Biotechnology is headquartered in Shenzhen, China.

  • What industry is Ailurus Biotechnology in?

    Ailurus Biotechnology’s primary industry is Discovery Tools (Healthcare).

  • Is Ailurus Biotechnology a private or public company?

    Ailurus Biotechnology is a Private company.

  • What is Ailurus Biotechnology’s current revenue?

    The current revenue for Ailurus Biotechnology is .

  • Who are Ailurus Biotechnology’s investors?

    5Y Capital, Shanghai Youwei Zhilin Investment Management, Miracleplus, Hello Tomorrow, and iGem Startups are 5 of 6 investors who have invested in Ailurus Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process